Resources
-
Patient Experience, Revisited: What Patients Say About Prescription Drug Affordability and Policies to Resolve Patient Hardships
The EACH/PIC Coalition is pleased to release results from Version 2.0 of our Patient Experience Survey: Prescription Drug Affordability and Unaffordability, an updated, patient-led analysis of how people actually experience […]
Beyond Drug Prices: Policy Reforms Patients Say Would Actually Help
Across the country, policymakers are working to address prescription drug affordability. Yet too often, these efforts focus narrowly on the...
Read More
If Patients Are the Goal, New Research Challenges Virginia Legislators to Rethink UPLs
EACH/PIC Coalition Urges Policymakers to Better Identify and Address Patient Challenges Richmond, VA (February 3, 2026) - The Ensuring Access...
Read More
Patient Experience, Revisited: What Patients Say About Prescription Drug Affordability and Policies to Resolve Patient Hardships
The EACH/PIC Coalition is pleased to release results from Version 2.0 of our Patient Experience Survey: Prescription Drug Affordability and...
Read More
EACH/PIC Statement on on CMS Release of Drugs Subject to Medicare Negotiation for IPAY 2028
January 28, 2026 On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) announced the next round of...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Policy Reviews for Ozempic and Trulicity
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB providing input on their policy review and consideration of...
Read More
EACH/PIC Coalition Submits Letter to VA Senate Committee Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Virginia Senate Education and Health Committee ahead of consideration of S.B. 271....
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on 2025 and 2026 Cost Reviews
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their January meeting. The letter urged caution as...
Read More
EACH/PIC Sends Letters to House Committees Ahead of Insurance Hearings
The EACH/PIC Coalition sent letters to leadership and members of the House Committee on Energy and Commerce Subcommittee on Health...
Read More
EACH/PIC Statement on Reintroduction of VA PDAB Bill
January 13, 2026 Legislation that would establish a Prescription Drug Affordability Board in Virginia with authority to set upper payment...
Read More
EACH/PIC Letter to CO PDAB on Stakeholder Workgroup Recommendations
The EACH/PIC Coalition submitted comments to the Colorado PDAB on the proposed recommendations for engaging patients in the cost review...
Read More
EACH/PIC Statement on CMS Announcement of Medicare MFN Proposed Rules
December 19, 2025 In follow-up to the Executive Order issued in May, the Centers for Medicare & Medicaid Services (CMS)...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on 2025 and 2026 Cost Reviews
The EACH/PIC Coalition submitted comments to the Oregon PDAB, in advance of their December meeting, providing input on the cost...
Read More
EACH/PIC Letter to CO PDAAC on Patient Engagement Recommendations
The EACH/PIC Coalition submitted comments to the Colorado PDAAC on their proposed recommendations for engaging patients in the cost review...
Read More
EACH/PIC Statement on CMS Release of Negotiated Medicare Prices
December 3, 2025 On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the Maximum Fair Prices...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Annual Report
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB providing input on the draft annual report to the...
Read More
EACH/PIC Sends Letter from 55 Orgs to Congress on Price Setting Policies
The EACH/PIC Coalition sent a letter to Members of Congress drawing attention to the limitations and potential harm of price-setting...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Cost Reviews and UPL Framework
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB, providing input and feedback on the drug reviews for Ozempic...
Read More
EACH/PIC Coalition Submits Letter to CO Senate and House Committees on Health and Human Services
Following the decision of the Colorado PDAB to implement an upper payment limit (UPL) for the drug Enbrel, the EACH/PIC...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Policy Recommendations
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their October meeting on policies proposed for the...
Read More
Colorado Newsline: Colorado becomes first state to cap price of prescription drug
By Sara Wilson Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap...
Read More
Colorado Sun: Colorado just became the first state to cap the price of a prescription drug. What comes next is uncertain.
By John Ingold An obscure Colorado board took an unprecedented step last week in an attempt to control the prices...
Read More
Inside Health Policy: Setting National Precedent, Colorado PDAB Approves UPL For Amgen’s Enbrel
By Luke Zarzecki The Colorado Prescription Drug Affordability Board voted Friday (Oct. 3) to set an upper payment limit (UPL)...
Read More
Bloomberg Law: Colorado Finalizes First State Payment Cap for Amgen’s Enbrel
By Celine Castronuovo Amgen Inc.‘s blockbuster biologic Enbrel will be the first product to face a state-imposed health plan payment...
Read More
EACH/PIC Coalition Open Letter to State Legislatures: A Better Way Than UPLs
There Is a Better Way to Help Patients Than PDABs and UPLs The Ensuring Access through Collaborative Health (EACH) and...
Read More
EACH/PIC Statement on CO PDAB Setting a UPL for Enbrel
October 3, 2025 Tiffany Westrich-Robertson, EACH/PIC Coalition founder and person living with an autoimmune condition, issued the following statement on...
Read More
EACH/PIC Coalition Submits Letter to CO PDAB on UPL Rulemaking for Enbrel
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their fourth rulemaking hearing to implement an upper...
Read More
EACH/PIC Coalition Submits Letter to WA PDAB on Public Surveys
The EACH/PIC Coalition submitted a comment letter to the Washington Prescription Drug Affordability Board (PDAB) sharing best practices on patient...
Read More
EACH/PIC Coalition Submits Letter to MN PDAB on Patient Engagement Best Practices
The EACH/PIC Coalition submitted a comment letter to the Minnesota Prescription Drug Affordability Board (PDAB) providing input for the board...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Policy Recommendations
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their September meeting on policies proposed for the...
Read More
EACH/PIC Coalition Submits Letters to MD PDAB on Cost Review Dossiers on Ozempic and Trulicity
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB, providing input and feedback on the dossiers developed as part...
Read More
EACH/PIC Coalition Submits Letter to MD PDASC on Policy Interventions for Jardiance and Farxiga
The EACH/PIC Coalition submitted a comment letter to the Maryland Prescription Drug Affordability Stakeholder Council (PDASC), providing input on determining...
Read More
EACH/PIC Coalition Submits Letter to CO PDAB on UPL Rulemaking for Enbrel
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their third rulemaking hearing to implement an upper...
Read More
EACH/PIC Coalition Submits Patient-Led Survey on Affordability to PDABs and Advisory Boards
The EACH/PIC Coalition submitted letters to Prescription Drug Affordability Boards and corresponding advisory boards in seven states, providing the findings...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Affordability Review Process
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their August meeting on the affordability review process...
Read More
PDABs Are Asking the Wrong Questions About Drug Affordability; Here’s What Patients Say Really Matters
Across the country, Prescription Drug Affordability Boards (PDABs) are working to bring down the cost of medications. We support the...
Read More
EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability
Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns EACH/PIC Coalition Urges Policymakers to Better...
Read More
EACH/PIC Coalition Submits Letter to WA PDAB on Drug Selection and Patient Engagement
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their meeting to make the final selection of...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Affordability Review Process
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their meeting to finalize their affordability review process...
Read More
EACH/PIC Submits Letter from 23 Orgs to CO PDAB on Enbrel UPL Hearing
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their second rulemaking hearing to implement an upper...
Read More
EACH/PIC Coalition Submits Letters to MD PDAB on Cost Review Dossiers on Farxiga and Jardiance
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB providing input and feedback on the dossiers developed as part...
Read More
EACH/PIC Coalition Submits Letter to MN PDAB/PDAAC on Affordability Questions
The EACH/PIC Coalition submitted a comment letter to the Minnesota Prescription Drug Affordability Advisory Council (PDAAC) providing input on a...
Read More
Nationwide PDAB Outlook: Mapping Existing and Potential PDABs
The first PDAB was established in Maryland in 2019 and since that time, more have been created in states across...
Read More
EACH/PIC Coalition Submits Letter to DE Gov Urging Veto of MFP Provision
The EACH/PIC Coalition submitted a letter to Delaware Governor Meyer urging him to veto a provision that would cap reimbursement...
Read More
EACH/PIC Submits Letter from 22 Orgs to CMS on Medicare Negotiation Program (IPAY 2028)
The EACH/PIC Coalition submitted comments to CMS on the Medicare Negotiation Program procedures for IPAY 2028. The comments provided input...
Read More
EACH/PIC Coalition Responds to CO PDAB RFI via Data Submission Guide for Enbrel Rulemaking
The EACH/PIC Coalition submitted information to the CO PDAB in response to the Data Submission Guide on Enbrel for the...
Read More
EACH/PIC Coalition Submits Letter to MD PDASC on UPL Implementation and Patient Protections
The EACH/PIC Coalition submitted a comment letter to the Maryland Prescription Drug Affordability Stakeholder Council (PDASC) providing input on the...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Affordability Review Process
The EACH/PIC Coalition submitted a comment letter to the Oregon PDAB providing input on the affordability review process, including RFIs,...
Read More
EACH/PIC Coalition Submits Letter to DE House Health Admin Committee Opposing MFP Provision
The EACH/PIC Coalition submitted written testimony to the Delaware House Health Administration Committee opposing a provision that would cap reimbursement...
Read More
EACH/PIC Coalition Submits Letter to MA Joint Committee on Healthcare Financing Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Massachusetts Joint Committee on Healthcare Financing ahead of consideration of S.875. The...
Read More
EACH/PIC Coalition Submits Letter to NV Governor Urging Veto of MFP Bill
The EACH/PIC Coalition sent a letter to Governor Lombardo urging him to veto AB 259, which would cap reimbursement rates...
Read More
EACH/PIC Coalition Submits Letter to NV Sen Finance Committee Opposing MFP Bill
The EACH/PIC Coalition submitted comments to the Nevada Senate Finance Committee opposing AB 259, which would cap reimbursement rates at...
Read More
EACH/PIC Coalition Submits Letter to NV Ways and Means Committee Opposing MFP Bill
The EACH/PIC Coalition submitted comments to the Nevada Assembly Ways and Means Committee opposing AB 259, which would cap reimbursement...
Read More
EACH/PIC Coalition Submits Letter to CO PDAB on UPL Rulemaking for Enbrel
The EACH/PIC Coalition submitted a comment letter to the CO PDAB for consideration during the rulemaking hearing to establish an...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Subset List and Affordability Review
The EACH/PIC Coalition submitted a comment letter to the OR PDAB on the subset list of drugs and insulin products...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Cost Review Process and Farxiga
The EACH/PIC Coalition submitted a comment letter to the MD PDAB on their ongoing cost review process and input to...
Read More
EACH/PIC Coalition Submits Letter to DE Senate Committee Opposing MFP Provisions
The EACH/PIC Coalition submitted comments to the Delaware Senate Health and Social Services Committee opposing provisions in SJR 7, which...
Read More
EACH/PIC Coalition Submits Letter to RI Senate Committee Opposing MFP Bill
The EACH/PIC Coalition submitted comments to the Rhode Island Senate Health and Human Services Committee opposing SB 468, which would...
Read More
EACH/PIC Coalition Submits Letter to MI House Committee Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Michigan House Committee on Government Operations ahead of consideration of S.B. 3-5....
Read More
EACH/PIC Coalition Submits Letter to MI Senate Committee Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Michigan Senate Committee on Finance, Insurance, and Consumer Protection ahead of consideration...
Read More
EACH/PIC Coalition Urges MD Governor to Veto PDAB Expansion Legislation
The EACH/PIC Coalition submitted a letter to Maryland Governor Wes Moore urging him to veto S.B. 357/H.B. 424, which would...
Read More
EACH/PIC Submits Letter to OR PDAB on Improving Public Engagement on Drug Reviews
The EACH/PIC Coalition submitted comments to the Oregon PDAB ahead of their April meeting, providing feedback on the current Request...
Read More
EACH/PIC Coalition Submits Letter from 25 Orgs to 7 States
The EACH/PIC Coalition submitted sign-on letters to legislators in 7 states urging them to oppose legislation to implement a local...
Read More
EACH/PIC Coalition Submits Letters to MD PDAB on Jardiance and Farxiga
The EACH Coalition submitted letters to the Maryland PDAB ahead of expected cost reviews of the two drugs Jardiance and...
Read More
EACH/PIC Coalition Submits Letter to NV Commerce and Labor Committee Opposing MFP Bill
The EACH/PIC Coalition submitted comments to the Nevada Assembly Commerce and Labor Committee opposing AB 259 that would cap reimbursement...
Read More
PIC Launches “PIC Voices” Site to Help Patients Engage with Policymakers
The Patient Inclusion Council wants to ensure that patients have a say in the policies that impact their healthcare. To...
Read More
EACH/PIC Submits Comments to CMS on 15 Drugs Selected for Negotiation for IPAY 2027
The EACH/PIC Coalition submitted comments to CMS on the 15 drugs selected for the Medicare Negotiation Program for IPAY 2027....
Read More
EACH/PIC Coalition Submits Letter to MD Senate Finance Committee Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Maryland Senate Committee on Finance ahead of consideration of S.B. 357. The...
Read More
EACH/PIC Coalition Submits Letter to VA Gov Urging Veto of PDAB Bill
The EACH/PIC Coalition wrote to Virginia Governor Youngkin ahead of his consideration of H.B. 1724, which would create a PDAB...
Read More
PIC Submits Letter to OR PDAB on Improving Patient Request for Information Form
The Patient Inclusion Council provided direct feedback to the OR PDAB from patients and caregivers on the design and questions...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Cost Reviews and Patient Engagement
The EACH/PIC Coalition submitted a comment letter to the OR PDAB on their ongoing cost review process, which included detailed...
Read More
EACH/PIC Coalition Submits Letter to VA Senate Finance and Appropriations Committee on PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Senate Committee on Finance and Appropriations ahead of consideration of H.B. 1724....
Read More
EACH/PIC Coalition Submits Comment Letter from 25+ Orgs on Proposed MD PDAB UPL Rules and Policies
The EACH Coalition submitted a comment letter on the proposed rules and policies the Maryland PDAB proposed to govern its...
Read More
EACH/PIC Coalition Submits Letters to MD House Health and Government Operations and Senate Finance Committees
The EACH/PIC Coalition submitted written testimony to the House Committee on Government Operations and the Senate Committee on Finance ahead...
Read More
EACH Coalition Submits Letters to MD PDAB on Jardiance and Farxiga
The EACH Coalition submitted letters to the Maryland PDAB ahead of expected cost reviews of the two drugs Jardiance and...
Read More
EACH Issues Statement on CMS Release of Drugs Subject to Medicare Negotiation
On January 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced the next round of 15 medications subject...
Read More
EACH/PIC Coalition Submits Letter to VA House Labor and Commerce Committee Opposing the Establishment of New PDAB
The EACH/PIC Coalition submitted a comment letter to the Labor and Commerce Committee in the Virginia House of Delegates. The...
Read More
EACH Coalition Submits Letter to WA PDAB on Drug Selection Criteria and Cost Reviews
As the Washington PDAB finalizes policies for its drug review process, the EACH Coalition submitted comments to the board emphasizing...
Read More
EACH Coalition Submits Letter to OR PDAB on Board Annual Policies
The EACH Coalition submitted comments to the Oregon board on the board’s annual policies. The letter included comments on posting...
Read More
EACH Coalition Submits Letter to OR PDAB on Board Policy Recommendations and Annual Report
The EACH Coalition submitted comments to the Oregon board on the proposed policy recommendations and draft annual PDAB report. The...
Read More
EACH Coalition Submits Sign-On Letter from 40+ Orgs to CO PDAB Urging Patient Orgs Have a Seat at the Table
The EACH Coalition submitted comments to the Colorado board on the updated redline versions of the affordability rule and policy...
Read More
EACH Coalition Submits Letter to OR PDAB on UPL Plan
The EACH Coalition submitted comments to the board providing input for their planned report to the Oregon legislature on a...
Read More
EACH Coalition Submits Letters to MD PDAB on Drugs Selected for Cost Reviews
The EACH Coalition submitted letters to the MD PDAB in response to a request for input on the first 4...
Read More
EACH Coalition Submits Letter to MD PDAB on UPL Implementation Rules and Policies
The EACH Coalition submitted comments to the MD PDAB in response to requested input on COMAR 14.01.05 (Policy Review, Final...
Read More
National Network Spotlight: Rare Access Action Project
The Rare Access Action Project (RAAP) is an ad hoc coalition advocating for solutions to rare disease patient access in...
Read More
EACH Coalition Submits Letter to MD Stakeholder Council on the UPL Action Plan
The EACH Coalition submitted comments to the stakeholder council providing input on the Maryland Upper Payment Limit Action Plan ahead...
Read More
EACH Coalition Submits Letter to MD PDAB on the UPL Action Plan
The EACH Coalition submitted comments to the board providing input on the Maryland Upper Payment Limit Action Plan ahead of...
Read More
EACH Coalition Submits Letter to CO PDAB on Affordability Rule and Policy / Procedure Redlines
The EACH Coalition submitted comments to the Colorado board on the updated redline versions of the affordability rule and policy...
Read More
National Network Spotlight: Aimed Alliance Presents During October Meeting
During the EACH Coalition monthly meeting for October, Aimed Alliance provided an update on their work around PDABs and highlighted...
Read More
EACH Coalition Submits Letter to CO PDAB on Affordability Review Rule Urging for More Patient Engagement
The EACH Coalition submitted comments ahead of the Stakeholder Meeting held on September 24th urging for increased patient engagement and...
Read More
EACH Coalition Submits Letter to WA PDAB on Drug Review Process
As the Washington PDAB reviews its drug review process, the EACH Coalition submitted comments to the board outlining concerns with...
Read More
EACH Coalition Submits Letter to MD PDAB on Draft UPL Plan
In response to the Maryland PDAB’s request for comments on their draft plan on Upper Payment Limits, the EACH Coalition...
Read More
EACH Coalition Submits Letter to OR PDAB on Drug Review Process
As the Oregon PDAB reviews its drug review process, the EACH Coalition submitted comments to the board outlining concerns with...
Read More
EACH Issues Statement on CMS Prices for First 10 Drugs Subject to Medicare Negotiation
“The EACH Coalition is dedicated to lowering drug costs for patients; however, we are concerned that price limits have little...
Read More
EACH Coalition Submits Letter to MD PDAB on Drug Reviews and UPLs
In response to the Maryland PDAB’s request for comments on their selection of six drugs for cost review, the EACH...
Read More
EACH Coalition Submits Testimony to WA PDAB on Therapeutic Alternatives
In response to the Washington PDAB’s request for input on therapeutic alternatives, the EACH Coalition submitted a testimony urging the...
Read More
EACH Coalition Submits Group Comments to CMS re: Medicare Drug Price Negotiation Guidance
As part of its ongoing effort to implement IRA changes to the Medicare Part D program, CMS issued Medicare Drug...
Read More
EACH Coalition Submits Letter to Colorado PDAB on Cosentyx and Stelara Unaffordability Decision
Following the decisions by the Colorado PDAB designating Cosentyx and Stelara as unaffordable to patients in Colorado, the EACH Coalition...
Read More
Patient 101: Prescription Drug Affordability Board
States across the country are creating Prescription Drug Affordability Boards. The boards are tasked with evaluating prescription drug costs in...
Read More
New to PDABs? Make Sure to Get the Facts
Americans are concerned about the affordability of everything from bread to prescription medications. That’s why headlines about PDABs lowering patient...
Read More
EACH Coalition Submits Group Letter to Maryland PDAB on Therapeutic Alternatives
In response to the Maryland PDAB’s request for input on therapeutic alternatives, the EACH Coalition submitted a group letter urging...
Read More
EACH Coalition Submits Letter to Colorado PDAB on Enbrel Unaffordability Decision
Following the decision by the Colorado PDAB designating Enbrel as unaffordable to patients in Colorado, the EACH Coalition submitted comments...
Read More
PIC Launches Patient-Created Survey on Drug Affordability and Access
More and more patients are reporting difficulty getting the medications they need to maintain their health. However, in our complicated...
Read More
Beyond Drug Prices: Policy Reforms Patients Say Would Actually Help
Across the country, policymakers are working to address prescription drug affordability. Yet too often, these efforts focus narrowly on the...
Read More
If Patients Are the Goal, New Research Challenges Virginia Legislators to Rethink UPLs
EACH/PIC Coalition Urges Policymakers to Better Identify and Address Patient Challenges Richmond, VA (February 3, 2026) - The Ensuring Access...
Read More
Patient Experience, Revisited: What Patients Say About Prescription Drug Affordability and Policies to Resolve Patient Hardships
The EACH/PIC Coalition is pleased to release results from Version 2.0 of our Patient Experience Survey: Prescription Drug Affordability and...
Read More
Colorado Newsline: Colorado becomes first state to cap price of prescription drug
By Sara Wilson Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap...
Read More
Colorado Sun: Colorado just became the first state to cap the price of a prescription drug. What comes next is uncertain.
By John Ingold An obscure Colorado board took an unprecedented step last week in an attempt to control the prices...
Read More
Inside Health Policy: Setting National Precedent, Colorado PDAB Approves UPL For Amgen’s Enbrel
By Luke Zarzecki The Colorado Prescription Drug Affordability Board voted Friday (Oct. 3) to set an upper payment limit (UPL)...
Read More
Bloomberg Law: Colorado Finalizes First State Payment Cap for Amgen’s Enbrel
By Celine Castronuovo Amgen Inc.‘s blockbuster biologic Enbrel will be the first product to face a state-imposed health plan payment...
Read More
EACH/PIC Coalition Open Letter to State Legislatures: A Better Way Than UPLs
There Is a Better Way to Help Patients Than PDABs and UPLs The Ensuring Access through Collaborative Health (EACH) and...
Read More
PDABs Are Asking the Wrong Questions About Drug Affordability; Here’s What Patients Say Really Matters
Across the country, Prescription Drug Affordability Boards (PDABs) are working to bring down the cost of medications. We support the...
Read More
EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability
Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns EACH/PIC Coalition Urges Policymakers to Better...
Read More
Nationwide PDAB Outlook: Mapping Existing and Potential PDABs
The first PDAB was established in Maryland in 2019 and since that time, more have been created in states across...
Read More
National Network Spotlight: Rare Access Action Project
The Rare Access Action Project (RAAP) is an ad hoc coalition advocating for solutions to rare disease patient access in...
Read More
National Network Spotlight: Aimed Alliance Presents During October Meeting
During the EACH Coalition monthly meeting for October, Aimed Alliance provided an update on their work around PDABs and highlighted...
Read More
Patient 101: Prescription Drug Affordability Board
States across the country are creating Prescription Drug Affordability Boards. The boards are tasked with evaluating prescription drug costs in...
Read More
New to PDABs? Make Sure to Get the Facts
Americans are concerned about the affordability of everything from bread to prescription medications. That’s why headlines about PDABs lowering patient...
Read More
Beyond Drug Prices: Policy Reforms Patients Say Would Actually Help
Across the country, policymakers are working to address prescription drug affordability. Yet too often, these efforts focus narrowly on the...
Read More
If Patients Are the Goal, New Research Challenges Virginia Legislators to Rethink UPLs
EACH/PIC Coalition Urges Policymakers to Better Identify and Address Patient Challenges Richmond, VA (February 3, 2026) - The Ensuring Access...
Read More
Patient Experience, Revisited: What Patients Say About Prescription Drug Affordability and Policies to Resolve Patient Hardships
The EACH/PIC Coalition is pleased to release results from Version 2.0 of our Patient Experience Survey: Prescription Drug Affordability and...
Read More
EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability
Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns EACH/PIC Coalition Urges Policymakers to Better...
Read More
Nationwide PDAB Outlook: Mapping Existing and Potential PDABs
The first PDAB was established in Maryland in 2019 and since that time, more have been created in states across...
Read More
PIC Launches “PIC Voices” Site to Help Patients Engage with Policymakers
The Patient Inclusion Council wants to ensure that patients have a say in the policies that impact their healthcare. To...
Read More
Patient 101: Prescription Drug Affordability Board
States across the country are creating Prescription Drug Affordability Boards. The boards are tasked with evaluating prescription drug costs in...
Read More
New to PDABs? Make Sure to Get the Facts
Americans are concerned about the affordability of everything from bread to prescription medications. That’s why headlines about PDABs lowering patient...
Read More
PIC Launches Patient-Created Survey on Drug Affordability and Access
More and more patients are reporting difficulty getting the medications they need to maintain their health. However, in our complicated...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Policy Reviews for Ozempic and Trulicity
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB providing input on their policy review and consideration of...
Read More
EACH/PIC Coalition Submits Letter to VA Senate Committee Opposing PDAB Bill
The EACH/PIC Coalition submitted written testimony to the Virginia Senate Education and Health Committee ahead of consideration of S.B. 271....
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on 2025 and 2026 Cost Reviews
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their January meeting. The letter urged caution as...
Read More
EACH/PIC Sends Letters to House Committees Ahead of Insurance Hearings
The EACH/PIC Coalition sent letters to leadership and members of the House Committee on Energy and Commerce Subcommittee on Health...
Read More
EACH/PIC Letter to CO PDAB on Stakeholder Workgroup Recommendations
The EACH/PIC Coalition submitted comments to the Colorado PDAB on the proposed recommendations for engaging patients in the cost review...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on 2025 and 2026 Cost Reviews
The EACH/PIC Coalition submitted comments to the Oregon PDAB, in advance of their December meeting, providing input on the cost...
Read More
EACH/PIC Letter to CO PDAAC on Patient Engagement Recommendations
The EACH/PIC Coalition submitted comments to the Colorado PDAAC on their proposed recommendations for engaging patients in the cost review...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Annual Report
The EACH/PIC Coalition submitted a comment letter to the Maryland PDAB providing input on the draft annual report to the...
Read More
EACH/PIC Sends Letter from 55 Orgs to Congress on Price Setting Policies
The EACH/PIC Coalition sent a letter to Members of Congress drawing attention to the limitations and potential harm of price-setting...
Read More
EACH/PIC Coalition Submits Letter to MD PDAB on Cost Reviews and UPL Framework
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB, providing input and feedback on the drug reviews for Ozempic...
Read More
EACH/PIC Coalition Submits Letter to CO Senate and House Committees on Health and Human Services
Following the decision of the Colorado PDAB to implement an upper payment limit (UPL) for the drug Enbrel, the EACH/PIC...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Policy Recommendations
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their October meeting on policies proposed for the...
Read More
EACH/PIC Coalition Open Letter to State Legislatures: A Better Way Than UPLs
There Is a Better Way to Help Patients Than PDABs and UPLs The Ensuring Access through Collaborative Health (EACH) and...
Read More
EACH/PIC Coalition Submits Letter to CO PDAB on UPL Rulemaking for Enbrel
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their fourth rulemaking hearing to implement an upper...
Read More
EACH/PIC Coalition Submits Letter to WA PDAB on Public Surveys
The EACH/PIC Coalition submitted a comment letter to the Washington Prescription Drug Affordability Board (PDAB) sharing best practices on patient...
Read More
EACH/PIC Coalition Submits Letter to MN PDAB on Patient Engagement Best Practices
The EACH/PIC Coalition submitted a comment letter to the Minnesota Prescription Drug Affordability Board (PDAB) providing input for the board...
Read More
EACH/PIC Coalition Submits Letter to OR PDAB on Policy Recommendations
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their September meeting on policies proposed for the...
Read More
EACH/PIC Coalition Submits Letters to MD PDAB on Cost Review Dossiers on Ozempic and Trulicity
The EACH/PIC Coalition submitted comment letters to the Maryland PDAB, providing input and feedback on the dossiers developed as part...
Read More
EACH/PIC Coalition Submits Letter to MD PDASC on Policy Interventions for Jardiance and Farxiga
The EACH/PIC Coalition submitted a comment letter to the Maryland Prescription Drug Affordability Stakeholder Council (PDASC), providing input on determining...
Read More
EACH/PIC Coalition Submits Letter to CO PDAB on UPL Rulemaking for Enbrel
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their third rulemaking hearing to implement an upper...
Read More
Beyond Drug Prices: Policy Reforms Patients Say Would Actually Help
Across the country, policymakers are working to address prescription drug affordability. Yet too often, these efforts focus narrowly on the...
Read More
If Patients Are the Goal, New Research Challenges Virginia Legislators to Rethink UPLs
EACH/PIC Coalition Urges Policymakers to Better Identify and Address Patient Challenges Richmond, VA (February 3, 2026) - The Ensuring Access...
Read More
EACH/PIC Statement on on CMS Release of Drugs Subject to Medicare Negotiation for IPAY 2028
January 28, 2026 On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) announced the next round of...
Read More
EACH/PIC Statement on Reintroduction of VA PDAB Bill
January 13, 2026 Legislation that would establish a Prescription Drug Affordability Board in Virginia with authority to set upper payment...
Read More
EACH/PIC Statement on CMS Announcement of Medicare MFN Proposed Rules
December 19, 2025 In follow-up to the Executive Order issued in May, the Centers for Medicare & Medicaid Services (CMS)...
Read More
EACH/PIC Statement on CMS Release of Negotiated Medicare Prices
December 3, 2025 On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the Maximum Fair Prices...
Read More
Colorado Newsline: Colorado becomes first state to cap price of prescription drug
By Sara Wilson Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap...
Read More
Colorado Sun: Colorado just became the first state to cap the price of a prescription drug. What comes next is uncertain.
By John Ingold An obscure Colorado board took an unprecedented step last week in an attempt to control the prices...
Read More
Inside Health Policy: Setting National Precedent, Colorado PDAB Approves UPL For Amgen’s Enbrel
By Luke Zarzecki The Colorado Prescription Drug Affordability Board voted Friday (Oct. 3) to set an upper payment limit (UPL)...
Read More
Bloomberg Law: Colorado Finalizes First State Payment Cap for Amgen’s Enbrel
By Celine Castronuovo Amgen Inc.‘s blockbuster biologic Enbrel will be the first product to face a state-imposed health plan payment...
Read More
EACH/PIC Statement on CO PDAB Setting a UPL for Enbrel
October 3, 2025 Tiffany Westrich-Robertson, EACH/PIC Coalition founder and person living with an autoimmune condition, issued the following statement on...
Read More
EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability
Patient-Led Survey Reveals Insurance Barriers and Personal Factors Contribute Significantly to Patient Affordability Concerns EACH/PIC Coalition Urges Policymakers to Better...
Read More
EACH Issues Statement on CMS Release of Drugs Subject to Medicare Negotiation
On January 17, 2025, the Centers for Medicare and Medicaid Services (CMS) announced the next round of 15 medications subject...
Read More
EACH Issues Statement on CMS Prices for First 10 Drugs Subject to Medicare Negotiation
“The EACH Coalition is dedicated to lowering drug costs for patients; however, we are concerned that price limits have little...
Read More